CIK 0001668397 · Services-Commercial Physical & Biological Research (SIC 8731) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 2.5 B | 1.5 B |
| Net income (USD) | 451.1 M | 245.4 M |
| Diluted EPS (USD/shares) | 15.28 | 7.28 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-14 | 4 | FORM 4 | 2026-10-12 |
| 2026-10-09 | 4 | FORM 4 | 2026-10-07 |
| 2026-10-02 | 4 | FORM 4 | 2026-09-30 |
| 2026-10-02 | 4 | FORM 4 | 2026-09-30 |
| 2026-10-02 | 4 | FORM 4 | 2026-09-30 |
| 2026-10-01 | 4 | FORM 4 | 2026-09-29 |
| 2026-09-29 | 4 | FORM 4 | 2026-09-25 |
| 2026-09-28 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-09-25 | 4 | FORM 4 | 2026-09-23 |
| 2026-09-23 | 4 | FORM 4 | 2026-09-21 |
| 2026-09-21 | 4 | FORM 4 | 2026-09-17 |
| 2026-09-17 | 4 | FORM 4 | 2026-09-15 |
| 2026-09-17 | 4 | FORM 4 | 2026-09-15 |
| 2026-08-31 | 4 | FORM 4 | 2026-08-27 |
| 2026-08-28 | 4 | FORM 4 | 2026-08-26 |
| 2026-08-27 | 4 | FORM 4 | 2026-08-25 |
| 2026-08-26 | 144 | 144 | |
| 2026-08-25 | 4 | FORM 4 | 2026-08-21 |
| 2026-08-24 | 4 | FORM 4 | 2026-08-20 |
| 2026-08-21 | 4 | FORM 4 | 2026-08-19 |
| 2026-08-21 | 4 | FORM 4 | 2026-08-19 |
| 2026-08-21 | 4 | FORM 4 | 2026-08-19 |
| 2026-08-20 | 144 | 144 | |
| 2026-08-19 | 144 | 144 | |
| 2026-08-19 | 144 | 144 |
Forms on file (last 1,000): 4 543, 8-K 89, 144 77, 10-Q 30, SC 13D/A 26, 3 23, SC 13G/A 16, UPLOAD 11. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=MEDP (0.002 USD), /gw/filings/filings?ticker=MEDP&form=8-K, /gw/filings/facts?ticker=MEDP&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange